American Cryostem's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of American Cryostem (CRYO) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: American Cryostem vs Its Competitors
- Peer revenue share: American Cryostem accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CRYO Sales vs. its Competitors, Q3 2022
American Cryostem generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs -67.2% for American Cryostem. American Cryostem's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
American Cryostem's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| American Cryostem Corporation | Yes | No | No | Yes |
| Similar Growth & Profitability (8) | 75.00 % (6 of 8) | 62.50 % (5 of 8) | 62.50 % (5 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.